The effectiveness of infliximab for Kawasaki disease in children: systematic review and meta-analysis

BACKGROUND: Kawasaki disease (KD) is a self-limited illness that results in coronary artery aneurysms (CAAs) and threatens children’s health and lives. The therapeutic effects of single intravenous immunoglobulin gamma (IVIG) vs. infliximab (IFX) (with or without IVIG) in young children with KD rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dan, Li, Xiaohui, Dou, Wenting, Zheng, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193009/
https://www.ncbi.nlm.nih.gov/pubmed/34189087
http://dx.doi.org/10.21037/tp-20-482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193009/
https://www.ncbi.nlm.nih.gov/pubmed/34189087
http://dx.doi.org/10.21037/tp-20-482

Ejemplares similares